ClearPoint Neuro (CLPT) EBT Margin Growth (5y) (2016 - 2026)
ClearPoint Neuro (CLPT) EBT Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50,932.00 |
| Dec 31, 2025 | -831.00 |
| Sep 30, 2025 | 8,638.00 |
| Jun 30, 2025 | 3,146.00 |
| Mar 31, 2025 | 877.00 |
| Dec 31, 2024 | -9,166.00 |
| Sep 30, 2024 | -2,268.00 |
| Jun 30, 2024 | 364.00 |
| Mar 31, 2024 | -298.00 |
| Dec 31, 2023 | 1,014.00 |
| Sep 30, 2023 | -3,698.00 |
| Jun 30, 2023 | -7,427.00 |
| Mar 31, 2023 | -209.00 |
| Sep 30, 2021 | -29,505.00 |
| Jun 30, 2021 | -32,812.00 |
| Mar 31, 2021 | 754,159.00 |
| Sep 30, 2020 | 649,540.00 |
| Jun 30, 2020 | 26,749.00 |
| Mar 31, 2020 | 24,159.00 |
| Dec 31, 2019 | 33,158.00 |